/other/Diamyd_Medical_AB_publ-logo.png?Expires=1750012927&Signature=CzTFwfu0QDKzeT9ZppFFB7t4NM23o~qM3ib~8VtWoGDSlmhG4uUzzVfyQro4ilcze86TiQII8bO~2luJABtzWLknOzzStl-EDa6VtQWu82Yt7WJow5XPWQcogj8hkCQq~HpTJcQm5jb6Hm3ZbjfVfLShudp9YKokfe853EWT3v5l5SqhCU~FI8huIKzXaFF6ce0fh9mK05M0wiF92SPsORlQurpxeObC4Ew~~3G4alkFVZts81g463v-gdDY5z8bqH3OiPBanuskG7p3C6zaPib0kpej0efxRI~wi6D4FxB8ZKF9lfFGwsx4A5az74Qut4ysPqb3lekuFwbEDZmKrw__&Key-Pair-Id=K6QMJA61RGOXQ){kind=logo}
Diamyd Medical AB (publ)
DMYD | FN
Overview
Corporate Details
- ISIN(s):
- SE0005162872 (+5 more)
- LEI:
- 5493003NP2HNQDEKB804
- Country:
- Sweden
- Address:
- BOX 7349, 103 90 STOCKHOLM
- Website:
- N/A
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
Diamyd Medical AB is a biotech company working on precision medicine for autoimmune diabetes. They are developing antigen-specific immunotherapies.
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| No filings match the current criteria. | ||||
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
Nattaro Labs AB | Sweden | NATTA | |
|
Neovacs | France | ALNEV | |
|
Newron Pharmaceuticals S.p.A. | Italy | NWRN | |
|
NextCell Pharma AB | Sweden | NXTCL | |
|
NextFerm Technologies Ltd. | Israel | NXFR | |
|
NFL Biosciences | France | ALNFL | |
|
Nortem BioGroup | Spain | MLBIO | |
|
Novo Nordisk | Denmark | NOVO | |
|
NRGene Technologies Ltd. | Israel | NRGN | |
|
NUFORMIX PLC | United Kingdom | NFX |